The Effect of CYP2C9 Genotype Variants in Type 2 Diabetes on the Pharmacological Effectiveness of Sulfonylureas, Diabetic Retinopathy, and Nephropathy

AIM: Type 2 diabetes (T2D), as a major cause of morbidity and mortality, is predicted to have a prevalence of 629 million by 2045. As diabetic patients show considerable inter-individual variation in response to antidiabetic treatment, this study aimed to investigate the gene polymorphism of cytochr...

Descripción completa

Detalles Bibliográficos
Autores principales: Saberi, Meisam, Ramazani, Zahra, Rashidi, Homeira, Saberi, Alihossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308133/
https://www.ncbi.nlm.nih.gov/pubmed/32606720
http://dx.doi.org/10.2147/VHRM.S230639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308133/
https://www.ncbi.nlm.nih.gov/pubmed/32606720
http://dx.doi.org/10.2147/VHRM.S230639

Ejemplares similares